We can study ultrarare tumors effectively in this day and age, it just takes a cooperative approach: The role of dasatinib in assorted indolent sarcomas

Dasatinib may be an active agent in assorted indolent sarcomas. The impact of endpoint selection, well‐defined cohorts, and responses (Choi criteria vs Response Evaluation Criteria in Solid Tumors) are discussed. See also pages 90‐7.

Detalles Bibliográficos
Autores principales: Villalobos, Victor M., Hoffner, Brianna, Elias, Anthony D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215314/
https://www.ncbi.nlm.nih.gov/pubmed/27696384
http://dx.doi.org/10.1002/cncr.30377
_version_ 1782491745693466624
author Villalobos, Victor M.
Hoffner, Brianna
Elias, Anthony D.
author_facet Villalobos, Victor M.
Hoffner, Brianna
Elias, Anthony D.
author_sort Villalobos, Victor M.
collection PubMed
description Dasatinib may be an active agent in assorted indolent sarcomas. The impact of endpoint selection, well‐defined cohorts, and responses (Choi criteria vs Response Evaluation Criteria in Solid Tumors) are discussed. See also pages 90‐7.
format Online
Article
Text
id pubmed-5215314
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-52153142017-01-18 We can study ultrarare tumors effectively in this day and age, it just takes a cooperative approach: The role of dasatinib in assorted indolent sarcomas Villalobos, Victor M. Hoffner, Brianna Elias, Anthony D. Cancer Editorials Dasatinib may be an active agent in assorted indolent sarcomas. The impact of endpoint selection, well‐defined cohorts, and responses (Choi criteria vs Response Evaluation Criteria in Solid Tumors) are discussed. See also pages 90‐7. John Wiley and Sons Inc. 2016-10-03 2017-01-01 /pmc/articles/PMC5215314/ /pubmed/27696384 http://dx.doi.org/10.1002/cncr.30377 Text en © 2016 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Editorials
Villalobos, Victor M.
Hoffner, Brianna
Elias, Anthony D.
We can study ultrarare tumors effectively in this day and age, it just takes a cooperative approach: The role of dasatinib in assorted indolent sarcomas
title We can study ultrarare tumors effectively in this day and age, it just takes a cooperative approach: The role of dasatinib in assorted indolent sarcomas
title_full We can study ultrarare tumors effectively in this day and age, it just takes a cooperative approach: The role of dasatinib in assorted indolent sarcomas
title_fullStr We can study ultrarare tumors effectively in this day and age, it just takes a cooperative approach: The role of dasatinib in assorted indolent sarcomas
title_full_unstemmed We can study ultrarare tumors effectively in this day and age, it just takes a cooperative approach: The role of dasatinib in assorted indolent sarcomas
title_short We can study ultrarare tumors effectively in this day and age, it just takes a cooperative approach: The role of dasatinib in assorted indolent sarcomas
title_sort we can study ultrarare tumors effectively in this day and age, it just takes a cooperative approach: the role of dasatinib in assorted indolent sarcomas
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215314/
https://www.ncbi.nlm.nih.gov/pubmed/27696384
http://dx.doi.org/10.1002/cncr.30377
work_keys_str_mv AT villalobosvictorm wecanstudyultrararetumorseffectivelyinthisdayandageitjusttakesacooperativeapproachtheroleofdasatinibinassortedindolentsarcomas
AT hoffnerbrianna wecanstudyultrararetumorseffectivelyinthisdayandageitjusttakesacooperativeapproachtheroleofdasatinibinassortedindolentsarcomas
AT eliasanthonyd wecanstudyultrararetumorseffectivelyinthisdayandageitjusttakesacooperativeapproachtheroleofdasatinibinassortedindolentsarcomas

Ejemplares similares